News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
62,718 Results
Type
Article (1390)
Company Profile (6)
Press Release (61322)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (31799)
Career Advice (37)
Deals (4463)
Drug Delivery (2)
Drug Development (6571)
Employer Resources (6)
FDA (1253)
Job Trends (1553)
News (42166)
Policy (2261)
Tag
Academia (107)
Accelerated approval (1)
Allergies (9)
Alliances (2003)
ALS (10)
Alzheimer's disease (119)
Antibody-drug conjugate (ADC) (8)
Approvals (1293)
Artificial intelligence (18)
Autoimmune disease (2)
Bankruptcy (13)
Best Places to Work (1481)
BIOSECURE Act (3)
Biosimilars (3)
Biotechnology (2)
Bladder cancer (12)
Brain cancer (3)
Breast cancer (43)
Cancer (293)
Cardiovascular disease (16)
Career advice (34)
Career pathing (1)
CAR-T (4)
Cell therapy (25)
Cervical cancer (4)
Clinical research (5895)
Collaboration (43)
Compensation (25)
COVID-19 (142)
CRISPR (3)
C-suite (6)
Cystic fibrosis (7)
Data (333)
Depression (5)
Diabetes (28)
Diagnostics (669)
Digital health (1)
Diversity, equity & inclusion (4)
Drug discovery (11)
Drug pricing (1)
Duchenne muscular dystrophy (10)
Earnings (29181)
Editorial (1)
Employer branding (1)
Employer resources (6)
Events (6356)
Executive appointments (21)
FDA (1476)
Frontotemporal dementia (2)
Funding (35)
Gene editing (5)
Generative AI (2)
Gene therapy (17)
GLP-1 (57)
Government (211)
Guidances (89)
Healthcare (1920)
IgA nephropathy (1)
Immunology and inflammation (11)
Indications (7)
Infectious disease (150)
Inflammatory bowel disease (10)
Influenza (3)
Intellectual property (4)
Interviews (7)
IPO (3287)
Job creations (156)
Job search strategy (30)
Kidney cancer (5)
Labor market (1)
Layoffs (31)
Leadership (1)
Legal (454)
Liver cancer (5)
Lung cancer (46)
Lymphoma (36)
Machine learning (1)
Management (1)
Manufacturing (16)
MASH (9)
Medical device (1591)
Medtech (1591)
Mergers & acquisitions (1248)
Metabolic disorders (64)
Multiple sclerosis (10)
NASH (2)
Neurodegenerative disease (2)
Neuropsychiatric disorders (2)
Neuroscience (172)
NextGen: Class of 2025 (417)
Non-profit (200)
Obesity (29)
Opinion (6)
Ovarian cancer (9)
Pain (9)
Pancreatic cancer (5)
Parkinson's disease (16)
Patents (8)
Patient recruitment (8)
Peanut (6)
People (1720)
Pharmaceutical (3)
Phase I (1292)
Phase II (2310)
Phase III (2664)
Pipeline (494)
Policy (4)
Postmarket research (250)
Preclinical (361)
Press Release (2)
Prostate cancer (18)
Psychedelics (1)
Radiopharmaceuticals (59)
Rare diseases (35)
Real estate (198)
Regulatory (1789)
Reports (7)
Research institute (103)
Resumes & cover letters (3)
Rett syndrome (1)
Schizophrenia (12)
Series A (4)
Series B (5)
Sickle cell disease (4)
Spinal muscular atrophy (18)
Startups (108)
Stomach cancer (1)
Supply chain (3)
Tariffs (1)
The Weekly (1)
Vaccines (41)
Weight loss (18)
Women's health (1)
Worklife (1)
Date
Last 7 days (218)
Last 30 days (432)
Last 365 days (4285)
2025 (1552)
2024 (4766)
2023 (5330)
2022 (6089)
2021 (6192)
2020 (5573)
2019 (3990)
2018 (3030)
2017 (2667)
2016 (2116)
2015 (3018)
2014 (2090)
2013 (1256)
2012 (1587)
2011 (1894)
2010 (1882)
Location
Africa (40)
Alabama (4)
Arizona (7)
Asia (4391)
Australia (412)
California (780)
Canada (218)
China (120)
Colorado (39)
Connecticut (36)
Delaware (38)
Europe (7445)
Florida (161)
Georgia (27)
Idaho (3)
Illinois (40)
India (3)
Indiana (48)
Japan (14)
Kansas (10)
Kentucky (3)
Louisiana (4)
Maine (12)
Maryland (118)
Massachusetts (630)
Michigan (27)
Minnesota (53)
Missouri (8)
Montana (3)
Nebraska (1)
Nevada (12)
New Hampshire (9)
New Jersey (320)
New York (241)
North Carolina (116)
Northern California (360)
Ohio (10)
Oklahoma (1)
Oregon (2)
Pennsylvania (184)
South America (91)
South Carolina (1)
Southern California (310)
Tennessee (4)
Texas (99)
United States (3114)
Utah (33)
Virginia (8)
Washington D.C. (4)
Washington State (86)
West Virginia (1)
Wisconsin (1)
62,718 Results for "68".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cell Culture Media Market Size to Hit USD 14.68 Billion by 2034
February 18, 2025
·
1 min read
Press Releases
U.S. Healthcare Contract Research Organization Market Size to Hit USD 29.68 Bn by 2034
February 27, 2025
·
1 min read
Press Releases
Epicrispr Biotechnologies Secures $68 Million Series B to Initiate Clinical Trial for First-in-Class Disease-Modifying Epigenetic Neuromuscular Therapy for FSHD
March 27, 2025
·
5 min read
Press Releases
Certa Therapeutics Expands GPR68 Platform through Acquisition of OccuRx
December 19, 2024
·
4 min read
Press Releases
Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering
December 23, 2024
·
5 min read
Drug Development
KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid Myelitis and the First Patient Dosed in the Phase 1 Study
KBio, one of the leading developers of new biological treatments derived from a plant-based production system, today announced that the United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for EV68-228-N, a human monoclonal IgG1 against the capsid of enterovirus D68 (EV-D68) designed as an intravenous therapeutic for the treatment of acute flaccid myelitis (AFM).
June 28, 2024
·
5 min read
Biotechnology Market Size to Reach USD 5.68 Trillion by 2033
According to the latest research by Nova One Advisor, the global biotechnology market size was valued at USD 1.54 Trillion in 2023 and is projected to reach USD 5.68 Trillion by 2033, growing at a CAGR of 13.95% from 2024 to 2033
April 3, 2024
·
17 min read
Generic Drugs Market Size to Worth Around USD 779.68 Bn by 2033
A recent market report published by nova one advisor, the global generic drugs market size was estimated at USD 465.19 billion in 2023 and is expected to be worth around USD 779.68 billion by 2033 with a CAGR of 5.3% from 2024 to 2033.
April 23, 2024
·
9 min read
Press Releases
Clear Aligners Market Surges to US$ 15.68 Billion by 2031, Coherent Market Insights
November 6, 2024
·
1 min read
Biologics Contract Development Market Size to Hit USD 18.68 Bn by 2033 | CAGR 8.2%
According to Nova One Advisor, the global biologics contract development market size was accounted for USD 8.49 billion in 2023 and it is increasing around USD 18.68 billion by 2033 with a CAGR of 8.2% from 2024 to 2033.
April 15, 2024
·
14 min read
1 of 6,272
Next
